The decisions that leaders make today about artificial intelligence governance and research priorities could create paths ...
Ro, the leading direct-to-patient healthcare company, today published the first study to evaluate both the long-term weight loss and safety outcomes of treatment with semaglutide via telehealth. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback